Onderneming Nautilus Biotechnology, Inc.
Aandelen
NAUT
US63909J1088
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,74 USD | -2,14% | +2,62% | -8,36% |
Vakgebied
Aantal werknemers: 163
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Parag Mallick
FOU | Founder | 47 | 01-01-16 |
Sujal Patel
FOU | Founder | 49 | 01-01-16 |
Anna Mowry
DFI | Director of Finance/CFO | 46 | 09-06-21 |
Mary Godwin
COO | Chief Operating Officer | 65 | 01-01-20 |
Public Communications Contact | - | 01-01-21 | |
Nick Nelson
PRN | Corporate Officer/Principal | 41 | 09-06-21 |
Martin Huber
PRN | Corporate Officer/Principal | - | 01/11 |
Subra Sankar
PRN | Corporate Officer/Principal | 64 | 01-12-20 |
Matthew Murphy
LAW | General Counsel | 59 | 09-06-21 |
Gwen Weld
HRO | Human Resources Officer | 66 | 12-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Posard
CHM | Chairman | 56 | 01-01-19 |
Farzad Nazem
BRD | Director/Board Member | 62 | 09-06-21 |
Matt McIlwain
BRD | Director/Board Member | 59 | 09-06-21 |
Sujal Patel
FOU | Founder | 49 | 01-01-16 |
Michael Altman
BRD | Director/Board Member | 42 | 09-06-21 |
Melissa Epperly
BRD | Director/Board Member | 46 | 09-06-21 |
Vijay Pande
BRD | Director/Board Member | 53 | 09-06-21 |
Parag Mallick
FOU | Founder | 47 | 01-01-16 |
Karen Akinsanya
BRD | Director/Board Member | 56 | 30-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 125 265 015 | 70 376 277 ( 56,18 %) | 0 | 56,18 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,36% | 351 mln. | |
+17,96% | 47,02 mld. | |
+48,77% | 41,86 mld. | |
+1,17% | 41,76 mld. | |
-4,27% | 28,8 mld. | |
+11,42% | 26,05 mld. | |
-21,39% | 19,15 mld. | |
+4,86% | 12,55 mld. | |
+27,29% | 12,34 mld. | |
-3,50% | 11,82 mld. |
- Beurs
- Aandelen
- Koers NAUT
- Onderneming Nautilus Biotechnology, Inc.